-
HPA031842-100UL
ANTI-C2ORF42 ANTIBODY PRODUCED IN RABBIT (C005B-208909)
Price: $970.54List Price: $1,078.38Immunogen chromosome 2 open reading frame 42 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization -
HPA043015-100UL
ANTI-CASC4 ANTIBODY PRODUCED IN RABBIT (C005B-212935)
Price: $1,013.20List Price: $1,125.78Immunogen cancer susceptibility candidate 4 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are -
HPA049488-100UL
ANTI-CASC4 ANTIBODY PRODUCED IN RABBIT (C005B-215355)
Price: $1,013.20List Price: $1,125.78Immunogen cancer susceptibility candidate 4 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are -
HPA056977-100UL
ANTI-CCDC130 ANTIBODY PRODUCED IN RABBIT
Price: $1,013.20List Price: $1,125.78Immunogen coiled-coil domain containing 130 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are -
HPA043468-100UL
ANTI-CCDC174 ANTIBODY PRODUCED IN RABBIT (C005B-213150)
Price: $1,013.20List Price: $1,125.78Immunogen chromosome 3 open reading frame 19 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are -
HPA045075-100UL
ANTI-CEACAM16 ANTIBODY PRODUCED IN RABBIT
Price: $1,013.20List Price: $1,125.78Immunogen carcinoembryonic antigen-related cell adhesion molecule 16 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) -
HPA023799-100UL
ANTI-CHMP4C (C005B-206230)
Price: $959.88List Price: $1,066.53Immunogen Charged multivesicular body protein 4c recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, -
HPA048530-100UL
ANTI-CLEC2A ANTIBODY PRODUCED IN RABBIT (C005B-215007)
Price: $1,013.20List Price: $1,125.78Immunogen C-type lectin domain family 2, member A recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a -
HPA042407-100UL
ANTI-CLRN2 (C005B-212661)
Price: $1,013.20List Price: $1,125.78Immunogen clarin 2 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most -
MABF2262-25UG
ANTI-COMPLEMENT RECEPTOR 1 CLONE 9H3 (C005B-450417)
Price: $346.00List Price: $384.45General description Soluble human complement receptor 1 Application Epitope: extracellular domain Quality Evaluated by Flow Cytometry in TF-1 cells. Flow Cytometry Analysis: 1 µg of this antibody detected Complement receptor 1 in one -
MABF2262-100UG
ANTI-COMPLEMENT RECEPTOR 1 CLONE 9H3 (C005B-450418)
Price: $820.37List Price: $911.52General description Soluble human complement receptor 1 Application Epitope: extracellular domain Quality Evaluated by Flow Cytometry in TF-1 cells. Flow Cytometry Analysis: 1 µg of this antibody detected Complement receptor 1 in one -
HPA053168-100UL
ANTI-CTXN2 ANTIBODY PRODUCED IN RABBIT
Price: $1,013.20List Price: $1,125.78Immunogen cortexin 2 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most